abstract: During human trophoblast differentiation, inhibin a subunit mRNA expression and protein secretion are increased. To understand how inhibin a subunit gene was regulated during syncytialization, we firstly cloned the inhibin a promoter and found a region with transcriptional activity related to the differentiation state. In this paper, we identified this protein and defined its DNA-binding site. Protein purification and identification were done by DNA affinity chromatography followed by mass spectrometry and western blotting. In order to confirm the identity of the protein, characterize its DNA-binding properties and to measure its expression during in vitro trophoblast differentiation, gel retardation assays and real-time polymerase chain reaction were done. We found that the cytotrophoblastic protein interacting with the inhibin a promoter was the transcription factor activating protein 2 (AP2). Western blotting using specific antibodies against AP2a and AP2g confirmed that AP2a was the main subtype present in trophoblast cells, while AP2g was barely detectable. Supershift experiments indicated that these two factors were able to bind to the sequence 5 ′ -GCCtcaAGC-3 ′ . We also observed an increase in AP2a mRNA and protein during in vitro trophoblast differentiation correlated with an increase in inhibin a subunit gene expression. Furthermore, AP2a and AP2g overexpression in these cells was responsible for an increase in inhibin a subunit mRNA expression. We conclude that AP2 regulates the inhibin a subunit gene expression during trophoblast differentiation and may be a key regulator of syncytialization.
Introduction
Among transforming growth factor (TGF) b superfamily, inhibin and activin are important factors for successful implantation of the blastocyst into the endometrium and placental vascularization (Jones et al., 2006) . These glycoproteins originally isolated from gonadal tissue are responsible for the regulation of the pituitary follicle-stimulating hormone secretion (Ying, 1988) . Inhibin and activin are a combination of three related protein subunits (a, bA and bB) encoded by separate genes. Activin is a dimer of two b subunits, while inhibin is formed of one a subunit disulfide linked to one of the two b subunits.
During pregnancy, the placenta is the main source of inhibin A and activin A (Muttukrishna et al., 1997; Florio et al., 2001) . Maternal serum concentrations increase rapidly during pregnancy up to 36 weeks' gestation (Fowler et al., 1998) . In pregnancies associated with Down's syndrome or complicated by pre-eclampsia, inhibin A concentration in maternal serum is significantly increased (Dalgliesh et al., 2001) . To the contrary, low inhibin A levels in early pregnancy are associated with subsequent spontaneous abortion risk (Muttukrishna et al., 2004) . Thus, inhibin A secretion is related to pregnancy complications due to placental disease. The mechanisms leading to inhibin concentration changes in pathological situations are unclear and a better knowledge of inhibin a gene regulation could help us to understand these modifications and physiopathological process.
Placental development starts just after implantation of the blastocyst into the endometrium (Depoix and Taylor, 2010) . Cytotrophoblastic cells proliferate extensively and invade the endometrium. They differentiate into hormone-secreting syncytiotrophoblastic cells which are polynucleated cells covering the villi. They are in direct contact with the maternal blood through the intervillous space. In vitro isolated cytotrophoblastic cells cultures differentiate spontaneously into syncytiotrophoblastic cells. During this fusion process, inhibin a subunit mRNA expression is correlated with increased inhibin A protein secretion into the cells supernatant (Debieve et al., 2000) . For a better understanding of the regulation of inhibin A expression during syncytialization, our laboratory cloned the inhibin a subunit gene promoter. We found by DNase protection assay that a sequence of the promoter was bound by a protein when cells were not yet undergoing differentiation (Debieve and Thomas, 2002) . Retardation assays using nuclear extracts prepared from isolated trophoblastic cells before culture and after 3 days in culture incubated with a probe corresponding to the protected fragment of the inhibin a promoter showed that the protein ability to interact with DNA was dependent on the differentiation state of the cells. Transfection assays with a reporter gene under control of the inhibin a promoter confirmed the importance of the sequence in the regulation of the inhibin expression in trophoblastic cells. Nevertheless this transcription factor was not identified.
The aims of this study based on human placental cells cultured in vitro are (i) to identify the transcription factor interacting with the inhibin a gene promoter, (ii) to characterize the DNA sequence responsible for this interaction, (iii) to confirm the effect of this factor on endogenous inhibin a subunit gene expression and (iv) to investigate a possible relationship between the expression of this factor and syncytium transformation.
Materials and Methods

Cytotrophoblastic cell isolation and purification
Isolated cytotrophoblastic cells were obtained from term placenta collected from uncomplicated pregnancies immediately after elective Cesarean section or vaginal delivery as previously described (Debieve et al., 2000) . All tissues were collected with the approval of the ethical committee at Université Catholique de Louvain. Briefly, isolation and purification consisted of dissociation of placental tissues by dispase II followed by digestion of extracellular DNA by DNase I. After serial filtrations followed by density centrifugation through a 5 -70% gradient Percoll (Sigma-Aldrich, Saint-Louis, MO, USA), the cellular fraction corresponding to a density of 1.048 -1.062 g/l was collected. Cells were further washed with fetal calf serum (FBS)-free Iscove's modified Dulbecco medium (IMDM; GibcoBRL Life Technologies, Paisley, UK) containing 50 IU/ml penicillin and 50 mg/ml streptomycin. The final cell pellet was either kept for nuclear protein extraction or resuspended in IMDM with 15% FBS and 50 IU/ml penicillin and 50 mg/ml streptomycin for cell culture experiments. Cell viability was assessed by Trypan Blue exclusion.
In this model, a contamination with 5% of cells from mesenchymal origin was previously demonstrated (Debieve et al., 2000) .
All experiments were repeated at least three times with three different placentae.
Nuclear protein extracts
Nuclear protein extraction from purified cytotrophoblastic cells was performed using NE-PER kit (Pierce, Rockford, illinois, USA) following the manufacturer protocol.
Transcription factor purification
Transcription factor purification was done using mMACS TM FactorFinder kit (Miltenyi Biotech Gmbh, Germany) and following a modified manufacturer protocol. Briefly, conditions of protein-DNA interaction were based on gelshift conditions (Debieve and Thomas, 2002) scaled up to allow purification of enough proteins for subsequent mass spectrometry (MS) analysis. Around 200 mg total nuclear proteins were incubated with 200 pmol biotinylated inhibin a oligos or 200 pmol non-specific oligos (see Table I for the list of all oligonucleotides used) in a binding buffer containing 10 mM Tris-HCl pH 7.5, 9% glycerol, 1 mM MgCl 2 , 10 mg poly(dI . dC), 0.5 mM EDTA, 150 mM NaCl, 0.5 mM dithiothreitol (DTT) and 100 mg BSA for 1 h at room temperature. Then, 100 ml mMACS TM streptavidin microbeads (Miltenyi Biotech Gmbh, Germany) were added to the binding reactions and incubated for 15 min at room temperature. Protein-DNA -mMACS beads were then loaded onto a mcolumn placed in a strong magnet. Washing and elution were done following the manufacturer protocol. The beads were washed at least four times with a low stringency buffer then four times with a high stringency buffer. Proteins interacting with DNA were eluted with either 50 ml elution buffer containing 1 M NaCl, 10 mM Tris-HCl pH 7.5 and 0.5 mM EDTA and immediately sent for MS analysis or with 250 ml mMACS TM native solution (high salt concentration) for further western blotting analysis. Proteins were precipitated for 1 h on ice with 10% trichloroacetate (TCA). After 1 h centrifugation at 15 000g, the pellet was washed with 500 ml cold acetone overnight at 2208C. After 30 min centrifugation at 15 000g, the pellet was air-dried and redissolved in 20 ml of 0.1 M NaOH.
Gel electrophoresis and Western blotting
Fifteen micrograms of nuclear extract and TCA-precipitated proteins from mMACS elution were loaded onto a 4 -12% gradient acrylamide/bisacrylamide NuPage w Novex w Bis-Tris minigel (Invitrogen, Carlsbad, CA, USA) and separated in 1× NuPage w MES SDS running buffer for 35 min at 200 V. Proteins were then transferred onto a nitrocellulose membrane (Amersham Hybond TM -ECL TM , GE Healthcare UK limited, Buckinghamshire, UK) 1 h at 100 V. After complete transfer, the membrane was blocked for 1 h in 5% non-fat dry milk in 1× PBS-T (50 mM Na/HPO 4 , 150 mM NaCl and 0.05% Tween-20) followed by overnight incubation at 48C with a mouse anti-activating protein 2 (AP2)a or anti-AP2g monoclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) diluted at 1/200 in 5% non-fat dry milk in 1× PBS-T. The membrane was washed three times with 1× PBS-T for 15 min each and then incubated for 1 h at room temperature with a 1/40 000 dilution of the anti-mouse Horseradish Peroxidase-conjugated antibody (Santa Cruz Biotechnology, Inc.) and bound antibody was detected using the ECL detection system (Amersham, GE Healthcare, Buckinghamshire, UK). 
Cell culture and transfections
Table I
List of oligonucleotide probes used for transcription factor purification.
AP2 regulates human inhibin a subunit gene expression cells. After 12 h, the medium was changed and cells cultured for 4 days. The medium was changed every day. Each day, two dishes were used for total RNA extraction and purification.
For transfection experiments, isolated cytotrophoblastic cells were cultured on 6-well plates at a density of 4.10 6 viable cells par well. Immediately after plating, cells in suspension were transfected with 500 ng per well of the following expression vectors: pCDNA3.1(+) (Invitrogen, Carlsbad, CA, USA), AP2a/pCDNA3.1(+) or AP2g/pCDNA3.1(+) using FuGENE w 6 (Roche Life Sciences, Mannheim, Germany) at a 1:3 ratio. AP2 expression vectors were kindly provided by Dr Ronald Weigel, University of Iowa, Iowa City, IA, USA. Cells were allowed to attach for 12 h and the medium was replaced. Attached cells were then transfected again with the same conditions. Forty-eight hours after the second transfection, cells were harvested for total RNA extraction and purification. All transfections were done in duplicate.
Electrophoretic mobility shift assay
Five micrograms of nuclear proteins was incubated in 10 ml containing 10 mM Tris-HCl pH 7.5, 1 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl and 4% glycerol for 10 min on ice. For competition experiments, 100-fold excess unlabeled probe was added to the binding reaction. For supershift experiments, 0.4 mg anti-AP2 antibodies were added to the reaction mixture. After incubation at 48C for 1 h, 25 fmol biotinylated probes were added and the reactions were kept at 48C for another 1 h (see Table II for list of oligos used).
One microliter of 10× loading buffer (250 mM Tris -HCl pH 7.5, 0.2% bromophenol blue, 40% glycerol) was added before loading. The DNA-protein complexes were then separated at 48C in a 4% acrylamide/ bisacrylamide (BioRad, Hercules, CA, USA) and 0.5× TBE gel at 350 V in 0.5× TBE (50 mM Tris, 45 mM borate and 0.5 mM EDTA pH 8.3) running buffer.
Free DNA and DNA -protein complexes were transferred onto a Byodine w B 0.45 mm modified nylon membrane (ThermoScientific-Pierce, Rockford, IL, USA) in 0.5× TBE buffer at 380 mA for 40 min and then UV cross linked. Complexes were visualized by chemiluminescence (Chemiluminescent Nucleic Acid Detection Module, Pierce).
RNA extraction
Total RNA was extracted from trophoblasts using the PureLink Micro-to-Midi total RNA Purification System (Invitrogen, Carlsbad, CA, USA) and quantified by absorbance at 260 nm in a NanoDrop TM 1000 spectrophotometer (Thermo-Fisher Scientific, Wilmington, DE, USA).
Reverse transcription and real-time polymerase chain reaction
Total RNA (0.5 mg) was used as template for reverse transcription in 20 ml reaction volume, using High Capacity RNA-to-cDNA Master Mix (Applied Biosystems, Foster City, CA, USA) then diluted five times with RNase-free water.
Two microliters of cDNA and 0.6 mM specific primers for human inhibin a subunit (forward: CAA-GTA-TGA-GAC-AGT-GCC-C; reverse: GCC-ATC-TAT-TTC-CCA-ACT-CTG), AP2a (forward: GTT-ACC-CTG-CTC-ACA-TCA-CTA-G; reverse: TCT-TGT-CAC-TTG-CTC-ATT-GGG), AP2g (forward: CGG-GAG-AAG-TTG-GAC-AAG-ATT-G; reverse: ATT-CGG-CTT-CAC-AGA-CAT-AGG) and RNA polymerase II (RPII) (forward: GCA-CCA-CGT-CCA-ATG-ACA-T; reverse: GTG-CGG-CTG-CTT-CCA-TAA) (Radonic et al., 2004) were added to SYBR Green Master Mix (Applied Biosystem). The PCR amplification was performed on a StepOne TM Realtime PCR system (Applied Biosystem) using the following thermal protocol: incubation at 958C for 10 min followed by 40 cycles of a denaturation step at 958C for 30 s, a hybridization step at 618C for 60 s and signal reading.
PCR reactions were performed in duplicate for each cDNA, averaged and normalized to RPII reference transcripts. The specificity of the amplification was determined by doing a melting curve (60-958C, read every 0.38C and hold 10 s) which generated single-peak product for each transcript.
RNA was quantified using the DDCt method of relative quantification using a Microsoft w Excel w Macro spreadsheet designed for gene expression analysis for iCycler iQ w Real-Time PCR Detection System (Bio-Rad).
Statistical analysis
Each experiment was done in triplicates, with the results normalized to control conditions for statistical analyses. The data are expressed as mean + standard error and were compared using Kruskall -Wallis test (GraphPad Prism w version 5.03 for Windows, GraphPad Software, San Diego, CA, USA). Two-tailed probabilities ,0.05 were considered statistically significant.
Results
In order to identify the transcription factor interacting with the inhibin a gene promoter, we used the DNA-binding properties of this transcription factor in electromobility shift assay (EMSA)-binding conditions applied to DNA affinity chromatography with 
Ecad1 TGGCCGGCAGGTGAACCCTCAGCCAATCAGCG
Ecad2 GTACGGGGGGCGGTGCTCCGGGGCTCACCTGGCTGCAG streptavidin-coated magnetic mMACS w beads. This procedure was scaled up to allow purification of enough proteins to be analyzed by MS. Nuclear protein extracts from isolated cytotrophoblastic cells were incubated with biotinylated double-stranded oligonucleotides corresponding to either the 2219 bp to 2185 bp inhibin a promoter fragment (S) or to a non-specific unrelated oligonucleotide (NS) corresponding to the multiple cloning site of pGL4 basic vector (Promega) ( Table I) . Streptavidin-coated magnetic mMACS w beads were added to the binding reaction and the mixtures were loaded onto a mcolumn placed into a strong magnetic field. Unbound proteins were removed by sequential washes with increasing ionic strength. Finally, bound proteins were eluted in their native state with a high salt solution. The eluted fraction was then analyzed by MS. Fine analysis of the spectra showed that there were two minor peaks corresponding to peptides related to the human transcription factor AP2, isoform alpha (data not shown). Sequences of the identified peptides were IGLNLPAGR and YKVTVAEVQR. By doing a protein sequence alignment between AP2a and AP2g, we found that the two MS peptides were located in the DNA-binding domain, a basic conserved region presenting 100% homology between the two proteins.
We confirmed by western blotting using monoclonal antibodies raised against AP2a and AP2g that these factors were interacting with the inhibin a promoter fragment. The factor purification was done according to the previously described protocol. Eluted proteins from each binding condition were TCA concentrated and loaded onto a denaturating polyacrylamide gel followed by western blotting (Fig. 1) . Cytotrophoblastic nuclear proteins were loaded onto lane 1 (NE) to confirm the presence of the factors in these cells (Fig. 1) . Lane 2 corresponds to the non-specific interaction (NS) and lane 3 corresponds to purification using the specific inhibin a promoter oligonucleotide (S). A band was detected at 52 kDa corresponding to the expected AP2 molecular weight. Cytotrophoblastic cells essentially expressed AP2a and very little AP2g. No AP2 factor was detected in the non-specific eluate. In the specific lane (S), only purified AP2a was detected. This confirms the MS results and the ability of this factor to interact in solution with the inhibin a promoter.
To validate our hypothesis, we visualized the protein -DNA interaction by EMSA. Cytotrophoblastic nuclear protein extracts were incubated with the inhibin a promoter oligonucleotide (Table II) . A very strong protein-DNA complex was formed and 100-fold excess of wild-type competitor (WT INH) completely removed the binding confirming the specificity of the interaction (Fig. 2) . Competition with an oligonucleotide containing a consensus sequence for AP2 (csAP2) strongly diminished the binding. To confirm that the protein recognized the AP2-binding site, we mutated the AP2 consensus sequence (mAP2). This oligonucleotide lost its competition ability, confirming that the protein interacting with the inhibin a promoter fragment was AP2. To define which AP2 protein interacted with the inhibin a promoter fragment, we added either anti-AP2a or anti-AP2g antibodies to the binding reactions. A supershift was formed with both antibodies indicating that the two subtypes interacted and bound in solution to our oligonucleotide. In respect of the previous western blotting results, we got a stronger supershift with the anti-AP2a antibody than with the anti-AP2g antibody.
All members of the AP2 family recognize and bind to the same DNA sequence with the same affinity as homo-or heterodimer. The consensus AP2-binding site is 5
′ -GCCN3GGC-3 ′ , with N corresponding to any nucleotide (Williams and Tjian, 1991) . Using this palindromic core sequence, we analyzed the inhibin a promoter fragment but could not find any homology. A study on the comparison of AP2-binding site specificity for AP2a and AP2g determined that the Figure 1 Western blotting of AP2 factors purified by DNA affinity chromatography. Cytotrophoblastic nuclear protein extracts were incubated with either biotinylated 2219/2185 inhibin a promoter (S, specific binding) or with a biotinylated unrelated probe (NS, nonspecific binding). Streptavidin-coated magnetic beads were then added and the mixture loaded onto a mcolumn placed into a magnetic field. After sequential washes with increasing ionic strength buffers, interacting proteins were eluted with 1 M NaCl elution buffer and analyzed by denaturating gel electrophoresis followed by western blotting using specific antibodies against human AP2a and AP2g. The presence of these factors in the cells was verified by loading 15 mg nuclear extract only (NE).
Figure 2 AP2 factors from undifferentiated cytotrophoblastic cells specifically bind to 2219/2185 inhibin a promoter. Biotinylated probe was incubated with 5 mg nuclear protein extract from undifferentiated cytotrophoblast cells (NE alone). Specificity was assessed by competition with 100-fold molar excess of unlabeled probe (cold WT INH). Endogenous AP2a and AP2g bind to the probe as demonstrated by competition experiments with 100-fold molar excess of unlabeled wild type and mutant consensus AP2 probe (csAP2) and supershift experiments using specific antibodies raised against APa and AP2g.
(1) AP2/DNA complex and (2) AP2 supershift.
AP2 regulates human inhibin a subunit gene expression consensus sequence for both factors was 5 and Weigel, 1999) . Using this consensus sequence as a template, we found a putative AP2-binding site 5 ′ -GCCtcaAGC-3 ′ from 2194 to 2202. To verify that this sequence was effectively an AP2-binding site, we mutated the first three nucleotides of the core sequence and used this oligonucleotide in competitive gel shift assay (Fig. 3) . This mutant oligonucleotide completely lost its ability to compete.*** Among the other possible transcription factors investigated by Debieve and Thomas in 2002, there was dEF1, a zinc finger protein known to bind to the ACCT sequence (Remacle et al., 1999) . While a competitor oligonucleotide derived from E-cadherin promoter containing a dEF1-binding site proved to be effective in suppressing the protein -DNA complex formation, the use of another dEF1-binding competitor derived from a4-integrin promoter did not compete meaning that this dEF1 factor was not binding to the ACCT sequence of the inhibin a promoter. E-cadherin is a transmembrane glycoprotein involved in cell -cell adhesion. During differentiation and fusion of the cytotrophoblasts, E-cadherin disappears (Coutifaris et al., 1991) . It is possible that E-cadherin may also be regulated by AP2 during syncytialization. We decided to define which part of the E-cadherin promoter fragment (Ecad) was able to compete for AP2 binding by using two competitor oligonucleotides corresponding to each half of the fragment, Ecad1 (5 ′ half) and Ecad2 (3 ′ half) (Table II) . Only Ecad2 was able to compete (Fig. 3 ). This part of the fragment has a 78% GC content and could harbor an AP2-binding site. EMSA experiments with the E-cadherin promoter fragment as a probe indicated that there was effectively an AP2-binding site in the 3 ′ end since the csAP2 oligonucleotide was able to compete for the protein -DNA complex formation (data not shown). During differentiation and fusion of the cytotrophoblastic cells, inhibin a subunit mRNA is up-regulated (Debieve et al., 2000) ( Fig. 4A ) and this up-regulation is correlated with an increase in dimeric inhibin A secretion in the supernatant. The 2246/+82 inhibin a promoter fragment possesses a transcriptional activity as shown by luciferase reporter gene assay in transfection experiments (Debieve and Thomas, 2002) . This transcriptional activity is located in the protected region of the promoter and we demonstrated here that the factor responsible for this regulation is AP2. We measured AP2a and AP2g mRNA expression by reverse transcription followed by quantitative real-time polymerase chain reaction (RT-qPCR) in cytotrophoblastic cells during in vitro syncytialization from Day 0 (D0) to Day 4 (D4). In undifferentiated cytotrophoblasts (D0), both AP2a and g mRNAs were expressed at the same level. After 1 day in culture, AP2a mRNA expression started to increase to reach a maximum of 1.6 fold at D3 (Fig. 4A ). This increase in messenger RNA was correlated with a trend in an increase in nuclear protein (Fig. 4B ), but nevertheless not statistically significant in densitometry analysis. To the contrary, AP2g mRNA expression was characterized by a 40% decrease at Day 1. From Day 2 to Day 4, mRNA levels increased again to reach the D0 level. These fluctuations in AP2g mRNA expression were not correlated with protein production.
To measure the effect of AP2 factors on the expression of endogenous inhibin a subunit gene, isolated cytotrophoblastic cells were transfected with AP2a and AP2g expression vectors (McPherson and Weigel, 1999) . A control experiment consisted of cytotrophoblastic cells transfected with the empty vector. Forty-eight hours after transfection, total RNA was extracted and purified. To verify the transfection efficiency, AP2a and AP2g relative expressions were quantified by RT-qPCR. AP2a and AP2g mRNA expressions were increased by 8.6-and 7.3-fold, respectively (Fig. 5A) . Transfection efficiency was also checked at the protein level with the expression of AP2 factors in empty and AP2a and AP2g expression vectors (Fig. 5C ). We then quantified the inhibin a subunit mRNA expression. In AP2a-overexpressing cells, inhibin a subunit mRNA expression was 1.2-fold increased over control and in AP2g-overexpressing cells, the effect was even stronger with a 1.34-fold increase over control (Fig. 5B) . This increase was statistically significant.
Discussion
During in vitro cytotrophoblast differentiation into syncytiotrophoblast, activin A is secreted during cellular aggregation while inhibin A is secreted during syncytialization (Debieve et al., 2000) . Inhibin a subunit is the limiting factor for inhibin A production and secretion, and could be also considered as a marker of syncytialization. Our laboratory cloned previously a 692 bp fragment of the human inhibin a promoter. DNAse I footprinting experiments using nuclear extracts from isolated cytotrophoblastic cells showed that a region corresponding to nucleotides 2221 to 2185 was protected. EMSA experiments with a probe corresponding to this protected region confirmed the interaction between the inhibin a promoter fragment and a cytotrophoblastic nuclear protein. This interaction appeared to be dependent on the differentiation state of the cells. The nuclear protein preferentially bound to the promoter when cells were Figure 3 Characterization and identification of the AP2-binding site in 2219/2185 inhibin a promoter by EMSA. We determined that the putative AP2 site was 5 ′ -GCCtcaAGC-3 ′ . Mutation of the first three nucleotides is able to suppress the ability of 100-fold unlabeled probe (cold mINH) to compete for AP2 binding. The AP2 site is also present in E-cadherin promoter fragment (WT ECad) and appears to be located in the 3 ′ half of the probe as indicated by competition results using two probes corresponding to each half of the WT ECad fragment (ECad1 and ECad2). undifferentiated. Moreover, transfection experiments with the inhibin a promoter fragment cloned into a luciferase reporter vector revealed that the protein presented activating transcriptional activity since deletion of the DNA-binding site abolished the luciferase activity (Debieve and Thomas, 2002) .
In this study, we purified and identified the factor(s) interacting with the inhibin a promoter by DNA affinity chromatography coupled to MS and western blotting. We found that the previously unidentified protein was a member of the AP2 family. In human and mouse, the family consists of five subtypes a, b, g, 1 and d (Eckert et al., 2005) . The AP2a, b and g factors were found to be important for embryonic development (Schorle et al., 1996) ; (Zhang et al., 1996) . Gene suppression experiments in mouse revealed that AP2a and b were involved in fetal development, while AP2g was important for placental formation (Auman et al., 2002) .
Human cytotrophoblastic cells isolated from term placenta differentially express AP2a and AP2g mRNA during in vitro syncytialization (Richardson et al., 2001 Cytotrophoblastic genes coding for human prolactin, human chorionic gonadotrophin a and g among others, are known to be increased during trophoblast fusion, and to be regulated by AP2 factors. Therefore, these transcription factors may play an essential role in regulating key genes of trophoblast differentiation. Overexpression of a dominant-negative mutant of AP2 in isolated cytotrophoblasts undergoing syncytialization revealed that inhibin a subunit was probably up-regulated by AP2 (Cheng et al., 2004) . Here, we measured AP2a and AP2g mRNA and protein expression during trophoblast differentiation. Interestingly, AP2a and AP2g mRNA expressions were partially different from those previously published (Richardson et al., 2001; Johnson et al., 1997) . AP2a is effectively increased during trophoblast differentiation at the mRNA level, but at the protein level, we only observed a trend without statistical significance. On the other hand, AP2g mRNA is decreased the first day of culture, which corresponds to cell aggregation. Then AP2g mRNA is increased again to reach the level measured in undifferentiated cytotrophoblasts. These changes in AP2g mRNA are not correlated with protein production, which stayed nearly undetected during the 4-day in vitro culture. These changes in AP2 factor expression are small but could play a role in transcriptional regulation of their target genes. Indeed, Figure 4 Inhibin a subunit mRNA, AP2 mRNA and protein expression during in vitro differentiation of cytotrophoblast cells. Cytotrophoblast cells were isolated and purified from term placentae and two groups of cells were cultured in vitro for 4 days (D0-D4). (A) One group of cells was used for total RNA extraction. After cDNA synthesis, inhibin a subunit, AP2a and AP2g cDNA were quantified by RT-qPCR and normalized to the internal control RPII gene. (B) Expression of AP2 factors during cytotrophoblast differentiation was assessed by western blotting, and densitometry analysis, using nuclear protein extracts prepared from another group of cells and loading control corresponds to detection of TATA-binding protein. Cytotrophoblast cells were obtained from three different placentae and cell culture was done in duplicate. *Statistically significant difference at P , 0.05 levels with Kruskall -Wallis test in mRNA expression increase relative to plating day (D0).
AP2 regulates human inhibin a subunit gene expression AP2a and g overexpressions in trophoblasts lead to 1.2-and 1.34-fold increase, respectively, in inhibin a subunit mRNA expression over mock-transfected control trophoblasts. This increase is statistically significant only for AP2g. The weak effect of AP2a and AP2g overexpression may be due to the fact that these cells are already expressing endogenous AP2a and AP2g. There could be also regulatory mechanisms involved since the cells are already undergoing syncytialization at the time of transfection. Primary trophoblasts purified and isolated from term placenta are not proliferating. They already express AP2a factors and their expression may be already at a maximum level, which would explain why the effect on inhibin a subunit expression is not more important. Nevertheless, our observations strongly support that AP2a regulates inhibin a subunit expression and production during the in vitro syncytialization.
Trophoblast fusion and syncytium formation are still unknown mechanisms. Studies on membrane glycoproteins expression during in vitro trophoblast differentiation indicated that E-cadherin, membrane retroviral envelop syncytin-1 and -2 and gap junctional proteins are essential. E-cadherin is not expressed in undifferentiated cytotrophoblasts (Coutifaris et al., 1991) . Once in culture, E-cadherin protein starts to appear reaching a peak after 24 h, when cells form aggregates. After 24 h, E-cadherin protein expression diminishes and is not detected anymore when cells are completely differentiated into syncytiotrophoblasts. This E-cadherin expression is correlated with the increase in AP2a mRNA expression and protein synthesis and with the decrease in AP2g mRNA expression seen at Day 1 in our 4-day cytotrophoblast cultures. Our competitive gel shift assay experiments also indicated that AP2 probably binds to an E-cadherin promoter fragment. We may speculate that AP2 factors are regulating key genes of syncytiotrophoblast formation. A defect in expression at the right time during trophoblast cellular fusion could lead to placental dysfunction as seen in pre-eclampsia (Brown et al., 2005) ; (Langbein et al., 2008) ) or in trisomy 21-affected placenta (Massin et al., 2001 ).
Figure 5
AP2a and AP2g overexpression in primary cytotrophoblast cells during in vitro differentiation increases inhibin a subunit gene expression. Twelve hours after plating, cytotrophoblast cells were transfected with 500 ng DNA using FuGENE w 6 transfection reagent and total RNA was extracted 48 h after transfection. Transfected plasmids were AP2a/pCDNA3.1(+), AP2g/pCDNA3.1(+) or the empty vector pCDNA3.1(+). After cDNA synthesis, AP2a, AP2g and inhibin a subunit were quantified by RT-qPCR. (A) Transfection efficiency was assessed by quantifying AP2a (black bars) and AP2g (grayed bars) mRNA in each group by RT-qPCR and western blot. (B) Inhibin a subunit mRNA expression is increased in AP2-overexpressing cells. Cells transfected with empty vector were considered as control (no TF) and the results were calculated as fold activity above control. Cytotrophoblast cells were obtained from three different placentae and cell culture was done in duplicate. mRNA quantification was done in duplicate and the results expressed as means + SEM. Statistically significant difference at P , 0.05 levels with Kruskall -Wallis test in mRNA expression increase relative to control.
